NIH-funded research R01 grant

Investigating early signs of Alzheimer's disease in adults in their sixties

Official title: Lifecourse Predictors and Mechanisms of Early Clinical ADRD among Black and White Adults in their Sixties

Funded at University of California, San Francisco · NIH-11054468 · Data updated 2026-11-12

This study is looking at how early signs of Alzheimer's disease show up in people in their sixties, focusing on things like genetics, heart health, and social connections, to help find ways to prevent and treat the disease better, especially for different groups of people.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Francisco
NIH-funded
Lab location1 site (San Francisco, United States)
Project startJanuary 1, 2025
Project endDecember 31, 2029
Funding year2025
Award (this year)$1,279,893
NIH project number1R01AG091431-01
Project IDNIH-11054468 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are Black and White adults in their sixties who are part of the CARDIA study.

Less likely to help

Patients outside of the age range or those not participating in the CARDIA study may not benefit from this research.

What this research studies

This research focuses on understanding how early signs of Alzheimer's disease and related disorders develop in adults during their sixties, particularly examining the roles of genetics, cardiovascular health, and social factors. By analyzing data from the Coronary Artery Risk Development in Young Adults (CARDIA) study, researchers will assess cognitive function and brain health in participants as they transition from midlife to late life. The goal is to identify early indicators of Alzheimer's disease to improve prevention and treatment strategies, especially in diverse populations.

Why it matters

Potential benefit: If successful, this research could lead to earlier detection and better prevention strategies for Alzheimer's disease, improving outcomes for patients.

How similar studies have gone: Previous research has shown promise in identifying early indicators of Alzheimer's disease, making this approach both relevant and potentially impactful.

Where this research is happening

  • University of California, San Francisco
    San Francisco, United States
    Active

Researchers

  • Principal investigator: Yaffe, Kristine — University of California, San Francisco
  • Study coordinator: Yaffe, Kristine

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.